logo

For the Inventor, By the Inventor

San Diego, CA, United States of America

Neuropore Therapies, Inc.

Calculating rank
USPTO Granted Patents = 12

% Expired Patents = 8.3



Trademarks = 2

Forward Citations = 20

Loading Chart...
Loading Chart...

7 inventors (with patents filed for the assignee):

goldMedal Wolfgang J Wrasidlo (12 out of 52 patents)

silverMedal Emily M Stocking (8 out of 22 patents)

bronzeMedal Srinivasa Reddy Natala (5 out of 12 patents)

4.  Diana Luz Price (3 out of 3 patents)

5.  Edward Rockenstein (1 out of 14 patents)

6.  Eliezer Masliah (1 out of 15 patents)

7.  Igor Flint Tsigelny (1 out of 3 patents)


12 patents:

1. 12049462 - Tri-substituted aryl and heteroaryl derivatives as modulators of PI3-kinase and autophagy pathways (2024-07-30),
2. 11708338 - Substituted phenyl sulfonyl phenyl triazole thiones and uses thereof (2023-07-25),
3. 11492348 - Tri-substituted aryl and heteroaryl derivatives as modulators of PI3-kinase and autophagy pathways (2022-11-08),
4. 11345713 - Compounds as modulators of TLR2 signaling (2022-05-31),
5. 11299487 - Compounds and compositions as modulators of TLR signaling (2022-04-12),
6. 11236079 - Morpholine derivates as inhibitors of Vps34 (2022-02-01),
7. 11008294 - Substituted phenyl sulfonyl phenyl triazole thiones and uses thereof (2021-05-18),
8. 10501423 - Substituted phenyl sulfonyl phenyl triazole thiones and uses thereof (2019-12-10),
9. 9738635 - Heteroaryl amides as inhibitors of protein aggregation (2017-08-22),
10. 9527852 - Phenyl-urea and phenyl-carbamate derivatives as inhibitors of protein aggregation (2016-12-27),
11. 9284309 - Di- and tri-heteroaryl derivatives as inhibitors of protein aggregation (2016-03-15),
12. 8846682 - Compound suitable for the treatment of synucleopathies (2014-09-30),
Company Overview
Neuropore Therapies, Inc. is a biotechnology company based in San Diego, California, focused on developing innovative therapies for neurodegenerative diseases. The company specializes in advancing treatments that target the underlying mechanisms of conditions such as Parkinson's disease and other related disorders. By leveraging cutting-edge research and technology, Neuropore aims to improve patient outcomes and enhance the quality of life for individuals affected by these challenging conditions.
Profile summary synthesized from public USPTO records and patent filings.

logo

Company Badge

USPTO Data Jan 1 1976 - Oct 27 2026

12 Patents

#448 in San Diego, CA

#6,069 in California

#25,589 in US

#48,235 in the World

San Diego, CA (US)
San Diego, CA, United States of America

Neuropore Therapies, Inc.

Forward Citations = 20

7 inventors:

goldMedal Wolfgang J Wrasidlo (12 out of 52 patents)

silverMedal Emily M Stocking (8 out of 22 patents)

bronzeMedal Srinivasa Reddy Natala (5 out of 12 patents)

4.  Diana Luz Price (3 out of 3 patents)

5.  Edward Rockenstein (1 out of 14 patents)

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Neuropore Therapies, Inc.. Retrieved from https://idiyas.com/company/neuropore-therapies

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…